
AI-generated antibodies tolerated by human immune cells
AI-generated antibodies have been tolerated by human immune cells, drug discovery company Latent Labs has announced. The antibody designs, generated by Latent Labs’ AI platform, reportedly displayed drug-like properties, including low ex vivo immunogenicity. Latent Labs hopes its platform, built on its Latent-X2 model, could significantly shorten… Read More













